Sale!

SMN1 Gene Spinal Muscular Atrophy Type 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SMN1 Gene Spinal Muscular Atrophy Type 3 Genetic Test is a specialized diagnostic tool designed to identify mutations in the SMN1 gene, which are indicative of Spinal Muscular Atrophy (SMA) Type 3. SMA Type 3, also known as Kugelberg-Welander disease, is a genetic disorder characterized by progressive muscle weakness and atrophy, primarily affecting the proximal muscles. This condition is caused by a reduction in the survival motor neuron protein due to mutations in the SMN1 gene.

This genetic test is crucial for early diagnosis, allowing for timely intervention and management of the condition. It involves analyzing the patient’s DNA to detect the presence of specific mutations in the SMN1 gene that are responsible for SMA Type 3. Early diagnosis through this test can significantly impact the patient’s quality of life, enabling access to supportive therapies and potential treatments that can slow the progression of the disease.

The test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the SMN1 Gene Spinal Muscular Atrophy Type 3 Genetic Test is 4400 AED. DNA Labs UAE employs cutting-edge technology and highly qualified professionals to ensure accurate and reliable test results, providing crucial information for patients and their families to manage SMA Type 3 effectively.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SMN1 Gene Spinal muscular atrophy type 3 Genetic Test

Components: Price 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for SMN1 Gene Spinal muscular atrophy type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SMN1 Gene Spinal muscular atrophy type 3.

Test Details

Spinal Muscular Atrophy Type 3 (SMA3) is a genetic disorder that affects the motor neurons in the spinal cord, leading to muscle weakness and atrophy. The SMN1 gene, specifically, is responsible for producing a protein called survival motor neuron (SMN) which is essential for the normal function of motor neurons.

NGS (Next-Generation Sequencing) Genetic Test refers to a type of genetic testing method that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. In the context of SMA3, an NGS Genetic Test can be performed to analyze the SMN1 gene and identify any genetic variations or mutations that may be associated with the condition.

The NGS Genetic Test for SMA3 involves obtaining a DNA sample, typically through a blood sample or cheek swab, from the individual undergoing testing. The DNA sample is then sequenced using NGS technology to analyze the SMN1 gene. The results of the test can help determine whether there are any mutations or variations in the SMN1 gene that may be causing or contributing to the development of SMA3.

This type of genetic testing can be useful for diagnosing SMA3, predicting the risk of developing the condition, and providing information for genetic counseling and family planning. It can also help guide treatment decisions and provide valuable information for ongoing research and development of potential therapies for SMA3.

Test Name SMN1 Gene Spinal muscular atrophy type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SMN1 Gene Spinal muscular atrophy type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SMN1 Gene Spinal muscular atrophy type 3
Test Details

Spinal Muscular Atrophy Type 3 (SMA3) is a genetic disorder that affects the motor neurons in the spinal cord, leading to muscle weakness and atrophy. The SMN1 gene, specifically, is responsible for producing a protein called survival motor neuron (SMN) which is essential for the normal function of motor neurons.

NGS (Next-Generation Sequencing) Genetic Test refers to a type of genetic testing method that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. In the context of SMA3, an NGS Genetic Test can be performed to analyze the SMN1 gene and identify any genetic variations or mutations that may be associated with the condition.

The NGS Genetic Test for SMA3 involves obtaining a DNA sample, typically through a blood sample or cheek swab, from the individual undergoing testing. The DNA sample is then sequenced using NGS technology to analyze the SMN1 gene. The results of the test can help determine whether there are any mutations or variations in the SMN1 gene that may be causing or contributing to the development of SMA3.

This type of genetic testing can be useful for diagnosing SMA3, predicting the risk of developing the condition, and providing information for genetic counseling and family planning. It can also help guide treatment decisions and provide valuable information for ongoing research and development of potential therapies for SMA3.